Metabolic engineering of Saccharomyces cerevisiae: a key cell factory platform for future biorefineries

被引:303
作者
Hong, Kuk-Ki [1 ,2 ]
Nielsen, Jens [1 ]
机构
[1] Chalmers Univ Technol, Novo Nordisk Ctr Biosustainabil, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden
[2] Biotechnol Res Inst, Seoul 157724, South Korea
关键词
Metabolic engineering; Yeast; Substrate range; Biobutanol; Isoprenoids; Industrial biotechnology; HIGH-LEVEL PRODUCTION; SYSTEMS BIOLOGY; YEAST-STRAIN; ALCOHOLIC FERMENTATION; GALACTOSE FERMENTATION; AMORPHOUS CELLULOSE; DIRECTED EVOLUTION; MEVALONATE PATHWAY; BUTANOL PRODUCTION; EXPRESSION;
D O I
10.1007/s00018-012-0945-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Metabolic engineering is the enabling science of development of efficient cell factories for the production of fuels, chemicals, pharmaceuticals, and food ingredients through microbial fermentations. The yeast Saccharomyces cerevisiae is a key cell factory already used for the production of a wide range of industrial products, and here we review ongoing work, particularly in industry, on using this organism for the production of butanol, which can be used as biofuel, and isoprenoids, which can find a wide range of applications including as pharmaceuticals and as biodiesel. We also look into how engineering of yeast can lead to improved uptake of sugars that are present in biomass hydrolyzates, and hereby allow for utilization of biomass as feedstock in the production of fuels and chemicals employing S. cerevisiae. Finally, we discuss the perspectives of how technologies from systems biology and synthetic biology can be used to advance metabolic engineering of yeast.
引用
收藏
页码:2671 / 2690
页数:20
相关论文
共 146 条
  • [61] Josling T., 2010, Biofuel and biomass subsidies in the US, EU and Brazil: towards a transparent system of notification IPC Position Paper
  • [62] Julien B, 2010, US Patent, Patent No. [US 2010/0151519 A1, 20100151519]
  • [63] Construction of a xylan-fermenting yeast strain through codisplay of xylanolytic enzymes on the surface of xylose-utilizing Saccharomyces cerevisiae cells
    Katahira, S
    Fujita, Y
    Mizuike, A
    Fukuda, H
    Kondo, A
    [J]. APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2004, 70 (09) : 5407 - 5414
  • [64] Keasling JD, 2010, US Patent, Patent No. [US 7670825, 7670825]
  • [65] Expression of hepatitis B surface antigen S domain in recombinant Saccharomyces cerevisiae using GAL1 promoter
    Kim, Eun-Jeong
    Park, Young-Kyoung
    Lim, Hyung-Kweon
    Park, Yong-Cheol
    Seo, Jin-Ho
    [J]. JOURNAL OF BIOTECHNOLOGY, 2009, 141 (3-4) : 155 - 159
  • [66] Optimizing the secondary structure of human papillomavirus type 16 L1 mRNA enhances L1 protein expression in Saccharomyces cerevisiae
    Kim, Hyoung Jin
    Lee, Seung Jae
    Kim, Hong-Jin
    [J]. JOURNAL OF BIOTECHNOLOGY, 2010, 150 (01) : 31 - 36
  • [67] A systems-level approach for metabolic engineering of yeast cell factories
    Kim, Il-Kwon
    Roldao, Antonio
    Siewers, Verena
    Nielsen, Jens
    [J]. FEMS YEAST RESEARCH, 2012, 12 (02) : 228 - 248
  • [68] KINNEY AJ, 2007, Patent No. 7256014
  • [69] Metabolic engineering of microorganisms for isoprenoid production
    Kirby, James
    Keasling, Jay D.
    [J]. NATURAL PRODUCT REPORTS, 2008, 25 (04) : 656 - 661
  • [70] Cloning of casbene and neocembrene synthases from Euphorbiaceae plants and expression in Saccharomyces cerevisiae
    Kirby, James
    Nishimoto, Minobu
    Park, J. Genevieve
    Withers, Sydnor T.
    Nowroozi, Farnaz
    Behrendt, Dominik
    Rutledge, Elizabeth J. Garcia
    Fortman, Jeffrey L.
    Johnson, Holly E.
    Anderson, James V.
    Keasling, Jay D.
    [J]. PHYTOCHEMISTRY, 2010, 71 (13) : 1466 - 1473